跳至主要内容
临床试验/NCT03219190
NCT03219190已完成不适用

A High School Program for Preventing Prescription Drug Misuse

National Health Promotion Associates, Inc.1 个研究点 分布在 1 个国家目标入组 1,804 人开始时间: 2022年2月1日最近更新:
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
1,804
试验地点
1
主要终点
Prescription Drug Misuse (i.e., Prescription Drug Use Without a Doctor's Prescription)

研究概览

简要总结

This project will develop and evaluate a program to prevent prescription drug misuse in high school students

详细描述

This Fast-Track SBIR project is designed to address the critical need for an effective primary prevention approach for prescription misuse (PDM), an urgent public health crisis in the United States. The project involves developing and testing an innovative new approach to the primary prevention of PDM among high school students utilizing e-learning and small group facilitator-led intervention modalities. The intervention is an adaptation of the evidence-based substance abuse prevention approach called Life Skills Training (LST). The adapted intervention will address the relationship between PDM and alcohol, tobacco and other drug (ATOD) use and abuse; positively change social norms surrounding ATOD and PDM; discourage diversion of prescription medications; enhance protective factors by building social and self-regulation skills through interactive learning and behavioral rehearsal scenarios.

Administrative Correction: This record was updated post-study to rectify administrative errors in the original registration and to reflect operational changes necessitated by the COVID-19 pandemic.

Correction of Secondary Outcomes: The Secondary Outcomes section has been corrected to include variables that were specified in several sections of the original registration and collected during the trial, but were inadvertently omitted from the "Outcome Measures" field in the initial registration. These include: alcohol use, tobacco use, marijuana use, inhalant use, perceived risk of prescription sedative, painkiller, and stimulant misuse, and life skills (self-regulation, communication, media resistance, anxiety management, refusal skills).

Update on Study Duration and Follow-up: The COVID-19 pandemic caused significant delays in study implementation and data collection. Although the original protocol specified 12- and 24-month follow-ups, the 24-month assessment was canceled because the study delays extended the timeline beyond the NIH/NIDA performance period. Additionally, widespread school closures and access restrictions resulted in high attrition at the 12-month time point, rendering those data insufficient for meaningful analysis. Consequently, the study analysis focuses exclusively on the immediate post-intervention timeframe.

Clarification on Terminology: Although our original grant application and ClinicalTrials.gov registration used the term Prescription Drug Abuse (PDA), we have adopted the more contemporary term Prescription Drug Misuse (PDM) to align with current best practices. PDM is defined here as the use of prescription drugs without a doctor's prescription.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
14 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Correction of Minimum and Maximum Ages: The correct minimum and maximum age range for the study population is ages 14-
  • Inclusion Criteria:
  • High school aged-youth

排除标准

  • All students in the classroom were eligible to participate in the intervention. However, at the discretion of local school staff, students with significant cognitive impairment or severe learning disabilities were excused from completing the study questionnaire.

研究组 & 干预措施

LST High School Hybrid

Experimental

Provided with the prevention program, consisting of e-learning modules and classroom sessions.

干预措施: LST High School Hybrid (Behavioral)

Treatment as Usual (Control)

No Intervention

Standard health education normally provided by the school

结局指标

主要结局

Prescription Drug Misuse (i.e., Prescription Drug Use Without a Doctor's Prescription)

时间窗: Assessed at pre-test and post-test assessment, post-test assessment approximately 2-4 weeks post-intervention reported

This measure includes prescription drug misuse of sedatives, painkillers, and stimulants. Frequency of sedative, painkiller, and stimulant use without a doctor's prescription; measured on a 9-point scale, including Never (1), A few times but NOT in the past year (2), A few times a year (3), Once a month (4), A few times a month (5), Once a week (6), A few times a week (7), Once a day (8), More than once a day (9); Unabbreviated scale title: Prescription Drug Misuse (i.e., prescription drug use without a doctor's prescription); Minimum value = 1; maximum value = 9; Higher scores are a worse outcome

次要结局

  • Substance Use Intentions(Assessed at pre-test and post-test assessment, post-test assessment approximately 2-4 weeks post-intervention reported)
  • Life Skills(Assessed at pre-test and post-test assessment, post-test assessment approximately 2-4 weeks post-intervention reported)
  • Alcohol Use(Assessed at pre-test and post-test assessment, post-test assessment approximately 2-4 weeks post-intervention reported)
  • Tobacco Use(Assessed at pre-test and post-test assessment, post-test assessment approximately 2-4 weeks post-intervention reported)
  • Marijuana Use(Assessed at pre-test and post-test assessment, post-test assessment approximately 2-4 weeks post-intervention reported)
  • Inhalant Use(Assessed at pre-test and post-test assessment, post-test assessment approximately 2-4 weeks post-intervention reported)
  • Perceived Risk of Prescription Drug Misuse(Assessed at pre-test and post-test assessment, post-test assessment approximately 2-4 weeks post-intervention reported)

研究者

申办方类型
Industry
责任方
Principal Investigator
主要研究者

Christopher Williams

Senior Research Scientist

National Health Promotion Associates, Inc.

研究点 (1)

Loading locations...

相似试验